drugset / Trial / NCT00557349
Ulcer Prevention Study in Post Gastric Bypass Patients
RandomizedParallel-groupDouble-blindPrevention
Summary
This research is to determine which medication, Zegerid (Omeprazole/Sodium Bicarbonate) or Pepcid AC (Famotidine), works best at reducing the chance that a patient will get an ulcer after gastric bypass surgery.
Timeline
- Start
- 2006-11
- Primary completion
- 2007-11
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Famotidine | Other / unclassified | 40 mg | — |
| Comparator | Omeprazole | Other / unclassified | 40 mg | — |